News Related to American Heart Association

Related coverage linked through entity extraction aliases.

Prothena Reports 2025 Results as Partners Advance Phase 3 Trials in Parkinson's, ATTR-CM

Mar 22, 2026

Prothena reported Q4 and full year 2025 financial results with $308.4 million in cash as partners Roche and Novo Nordisk initiated Phase 3 trials for prasinezumab and coramitug, both expected to complete in 2029.

CRISPR Gene Editing Advances in Heart Failure, Cystic Fibrosis, and Cholesterol Treatment

Mar 09, 2026

Three new CRISPR-based therapies show promise for treating heart failure through mitochondrial enhancement, cystic fibrosis via lipid nanoparticle gene insertion, and elevated cholesterol with single-dose gene editing targeting ANGPTL3.